MICROORGANISMS AND ONCOLOGY: THE ROLE OF BACTERIA IN CANCER DEVELOPMENT AND TREATMENT
Keywords:
microorganisms, bacteria, oncology, cancer development, carcinogenesis, microbiome, tumor progression, cancer treatment, bacterial therapy, immune modulation.Abstract
This paper explores the complex relationship between microorganisms, particularly bacteria, and oncology. Recent research has highlighted the significant role that certain bacterial species play in both the development and progression of cancer. Some bacteria contribute to carcinogenesis through mechanisms such as chronic inflammation, production of carcinogenic metabolites, and modulation of the immune response. Conversely, beneficial bacteria can influence tumor suppression and enhance the effectiveness of cancer treatments. The emerging field of microbiome research has opened new avenues for understanding how microbial communities impact cancer risk, progression, and therapy response. Furthermore, bacterial-based therapies, including probiotics, antibiotics, and engineered bacteria, are being investigated as potential adjuncts in cancer treatment. This review summarizes current knowledge on the dual role of bacteria in oncology and emphasizes the importance of targeting the microbiome for improved cancer prevention and therapy strategies.
Downloads
References
Garrett, W.S. (2015). Cancer and the microbiota. Science, 348(6230), 80-86. https://doi.org/10.1126/science.aaa4972
Zitvogel, L., Ma, Y., Raoult, D., Kroemer, G., & Gajewski, T.F. (2018). The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies. Science, 359(6382), 1366-1370. https://doi.org/10.1126/science.aar6918
Schwabe, R.F., & Jobin, C. (2013). The microbiome and cancer. Nature Reviews Cancer, 13(11), 800-812. https://doi.org/10.1038/nrc3610
Kostic, A.D., Chun, E., Robertson, L., Glickman, J.N., Gallini, C.A., Michaud, M., … & Garrett, W.S. (2013). Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host & Microbe, 14(2), 207-215. https://doi.org/10.1016/j.chom.2013.07.007
Plottel, C.S., & Blaser, M.J. (2011). Microbiome and malignancy. Cell Host & Microbe, 10(4), 324-335. https://doi.org/10.1016/j.chom.2011.10.003
Schwabe, R.F., & Jobin, C. (2013). The microbiome and cancer. Nature Reviews Cancer, 13(11), 800-812. https://doi.org/10.1038/nrc3610
Kamarajah, S.K., Bundred, N.J., Xu, L., & Hanna, G.B. (2021). The role of the microbiome in cancer development and therapy: A review. Clinical and Translational Oncology, 23(5), 964-974. https://doi.org/10.1007/s12094-020-02525-2
Gopalakrishnan, V., Spencer, C.N., Nezi, L., Reuben, A., Andrews, M.C., Karpinets, T.V., … & Wargo, J.A. (2018). Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients. Science, 359(6371), 97-103. https://doi.org/10.1126/science.aan4236
Bullman, S., Pedamallu, C.S., Sicinska, E., Clancy, T.E., Zhang, X., Cai, D., … & Meyerson, M. (2017). Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science, 358(6369), 1443-1448. https://doi.org/10.1126/science.aal5240
Wong, S.H., & Yu, J. (2019). Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nature Reviews Gastroenterology & Hepatology, 16(11), 690-704. https://doi.org/10.1038/s41575-019-0173-7
Zitvogel, L., Daillère, R., Roberti, M.P., Routy, B., & Kroemer, G. (2017). Anticancer effects of the microbiome and its products. Nature Reviews Microbiology, 15(8), 465-478. https://doi.org/10.1038/nrmicro.2017.44
Baxter, N.T., Zackular, J.P., Chen, G.Y., & Schloss, P.D. (2014). Structure of the gut microbiome following colonization with human feces determines colonic tumor burden. Microbiome, 2, 20. https://doi.org/10.1186/2049-2618-2-20
Zitvogel, L., Kroemer, G., & Ma, Y. (2018). The microbiome and anticancer immunosurveillance. Cell, 172(1-2), 130-142. https://doi.org/10.1016/j.cell.2017.12.004
Alexander, J.L., Wilson, I.D., Teare, J., Marchesi, J.R., Nicholson, J.K., & Kinross, J.M. (2017). Gut microbiota modulation of chemotherapy efficacy and toxicity. Nature Reviews Gastroenterology & Hepatology, 14(6), 356-365. https://doi.org/10.1038/nrgastro.2017.32
Zitvogel, L., Ma, Y., & Kroemer, G. (2019). Microbiome and anticancer immunosurveillance. Cancer Discovery, 9(9), 1271-1285. https://doi.org/10.1158/2159-8290.CD-19-0600
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
